CURRENT MANAGEMENT AND TREATMENT INDICATIONS OF BASELINE GREY- ZONE ( GZ) PATIENTS WITH HBEAG- NEGATIVE CHRONIC HEPATITIS B VIRUS INFECTION ( CHBVE-) IN GREECE

被引：0
|
作者：
Papatheodoridi, Margarita [1 ]
Paraskevopoulou, Sofia [2 ]
Ioannidou, Panagiota [2 ]
Fytili, Paraskevi [2 ]
Karagiannakis, Dimitrios [2 ]
Cholongitas, Evangelos [2 ]
Vlachogiannakos, Ioannis [2 ]
Papatheodoridis, George [2 ]
机构：
[1] Med Sch Athens Univ, Athens, Greece
[2] Gen Hosp Athens Laiko, Athens, Greece
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
277
引用
收藏
页码：S197 / S198
页数：2
相关论文
共 50 条
  • [21] Treatment of hepatitis B virus infection in chronic infection with HBeAg-positive adult patients (immunotolerant patients): a systematic review
    Tovo, Cristiane, V
    Ahlert, Marcelo
    Panke, Carine
    de Mattos, Angelo Z.
    de Mattos, Angelo A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (05) : 605 - 609
  • [22] The Impact of the Definitions of Clinical Phases on the Profiles of Grey-Zone Patients with Chronic Hepatitis B Virus Infection
    Xu, Xiaoqian
    Wang, Hao
    Shan, Shan
    Sun, Yameng
    Xu, Xiaoyuan
    You, Hong
    Jia, Jidong
    Zhuang, Hui
    Kong, Yuanyuan
    VIRUSES-BASEL, 2023, 15 (05):
  • [23] INDICATIONS FOR LIVER BIOPSY IN HBeAg-NEGATIVE CHRONIC HEPATITIS B VIRUS INFECTION WITH PERSISTENTLY NORMAL ALT. REAL LIFE STUDY
    Chaouch, H.
    Ben Jazia, E.
    Bellazreg, F.
    Hattab, Z.
    Mrad, S.
    Braham, A.
    Letaief, A. Omezzine
    JOURNAL OF HEPATOLOGY, 2013, 58 : S168 - S168
  • [24] Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection
    Guner, Rahmet
    Karahocagil, Mustafa
    Buyukberber, Mehmet
    Kandemir, Ozlem
    Ural, Onur
    Usluer, Gaye
    Inan, Dilara
    Koksal, Iftihar
    Baykam, Nurcan
    Hizel, Kenan
    Yamazhan, Tansu
    Esen, Saban
    Tasyaran, Mehmet A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (12) : 1185 - 1191
  • [25] Peripheral and intrahepatic virological phenotyping in HBeAg negative Chronic Hepatitis B to evaluate risk of disease progression and HCC in the "grey-zone" viral load cohort: Can grey-zone patients be candidate to treatment?
    Salpini, R.
    Colagrossi, L.
    Battisti, A.
    Hansi, N.
    Perno, C. F.
    Gill, U. S.
    Kennedy, P. T. F.
    Svicher, V.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E7 - E7
  • [26] Favourable Prognosis of Patients With Untreated HBeAg-Negative Chronic Hepatitis B Virus Infection With HBsAg < 100 IU/mL
    Wang, Jian
    Zhang, Zhiyi
    Yin, Shengxia
    Zhang, Shaoqiu
    Zhu, Li
    Pan, Yifan
    Fan, Tao
    Cao, Fei
    Xiong, Ye
    Jiang, Chao
    Wang, Guiyang
    Yang, Yue
    Jia, Bei
    Liu, Jiacheng
    Xia, Juan
    Yan, Xiaomin
    Li, Jie
    Zhu, Chuanwu
    Liu, Xingxiang
    Chen, Yuxin
    Wu, Chao
    Huang, Rui
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (03) : 472 - 480
  • [27] HEPATITIS B CORE-RELATED ANTIGEN LEVEL STRATIFIES CIRRHOSIS RISK IN HBEAG-NEGATIVE PATIENTS IN GREY ZONE OF ANTIVIRAL TREATMENT
    Tseng, Taichung
    Liu, Chun-Jen
    Su, Tung-Hung
    Yang, Hung-Chih
    Liu, Chen-Hua
    Chen, Pei-Jer
    Kao, Jia-Horng
    HEPATOLOGY, 2021, 74 : 458A - 458A
  • [28] Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: A systematic review
    Papatheodoridis, George V.
    Manolakopoulos, Spilios
    Liaw, Yun-Fan
    Lok, Anna
    JOURNAL OF HEPATOLOGY, 2012, 57 (01) : 196 - 202
  • [29] PEGINTERFERON ALFA2b PLUS TDF TREATMENT IN ADULTS WITH HBEAG- POSITIVE CHRONIC HEPATITIS B VIRUS INFECTION: A PILOT, OPEN- LABEL, PROSPECTIVE COHORT STUDY
    Liu, Min
    Zuo, Lili
    Zhang, Yuting
    Xiao, An
    Wang, Yilan
    Bu, Bing
    Chen, Jiayi
    Zhu, Ling
    Yue, Wei
    Geng, Jiawei
    Xia, Xueshan
    HEPATOLOGY, 2023, 78 : S537 - S538
  • [30] Correlation between baseline genotype and antiviral response to emtricitabine 200 mg QD among HBeAg negative patients with chronic hepatitis B infection
    Snow, A
    Guan, R
    Diamantis, I
    Sorbel, J
    Mondou, E
    Rousseau, F
    HEPATOLOGY, 2004, 40 (04) : 654A - 654A
12345